- ANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression
- JAMA Psychiatry
- Toward a New Standard in Inpatient Psychiatry
- Pragmatic Comparative Effectiveness of Primary Care Treatments for PTSD
- Prenatal and Early Postnatal Lead Exposure, Sensitive Periods, and Later Adult Mental Health
- Serial Ketamine Infusions for Depression
- Short-Term Trials Underestimate Antidepressant Withdrawal—Reply
- Short-Term Trials Underestimate Antidepressant Withdrawal
- Error in Conflict of Interest Disclosures
- New Reduced Drinking Goals in Alcohol Pharmacotherapy Trials
- Financing Variables and Behavioral Health Policy Implementation Research
- WHO Drinking Levels as a Primary Efficacy End Point for Alcohol Clinical Trials
- Exercise and Hippocampal Integrity in Adults With Cannabis Use Disorder
- Heart Rate Variability Biofeedback for Substance Use Disorder
- Brief Cognitive Behavioral Therapy for Suicidal Military Personnel and Veterans
